[HTML][HTML] First-line afatinib versus chemotherapy in patients with non–small cell lung cancer and common epidermal growth factor receptor gene mutations and brain …
Introduction Metastatic spread to the brain is common in patients with non–small cell lung
cancer (NSCLC), but these patients are generally excluded from prospective clinical trials …
cancer (NSCLC), but these patients are generally excluded from prospective clinical trials …
[HTML][HTML] Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of central nervous system metastases from non-small cell lung cancer: the present …
C Proto, M Imbimbo, R Gallucci, A Brissa… - … lung cancer research, 2016 - ncbi.nlm.nih.gov
Lung cancer is one of the major causes of cancer related mortality worldwide. Brain
metastases (BM) complicate clinical evolution of non-small cell lung cancer (NSCLC) in …
metastases (BM) complicate clinical evolution of non-small cell lung cancer (NSCLC) in …
The role of EGFR-TKI for leptomeningeal metastases from non-small cell lung cancer
X Yufen, S Binbin, C Wenyu, L Jialiang, Y Xinmei - Springerplus, 2016 - Springer
Leptomeningeal metastasis (LM) is a terminal event in the development of non-small cell
lung cancer (NSCLC). It has a poor prognosis with median survival of 1.9 months if …
lung cancer (NSCLC). It has a poor prognosis with median survival of 1.9 months if …
Impact of whole brain radiation therapy on CSF penetration ability of Icotinib in EGFR-mutated non-small cell lung cancer patients with brain metastases: results of …
L Zhou, J He, W Xiong, Y Liu, J Xiang, Q Yu, M Liang… - Lung Cancer, 2016 - Elsevier
Objectives Whole-brain radiation therapy (WBRT) and epidermal growth factor receptor
tyrosine kinase inhibitors (EGFR-TKIs) are both treatment options for EGFR-mutated non …
tyrosine kinase inhibitors (EGFR-TKIs) are both treatment options for EGFR-mutated non …
Tyrosine kinase inhibitors for EGFR-and ALK-mutated non-small cell lung cancer
JR Thompson, SP Menon, GK Dy - Admet and Dmpk, 2016 - hrcak.srce.hr
Sažetak Discovery of the epidermal growth receptor (EGFR) activating mutations and
anaplastic lymphoma kinase (ALK) rearrangements has expanded the therapeutic …
anaplastic lymphoma kinase (ALK) rearrangements has expanded the therapeutic …
Complete remission through icotinib treatment in Non-small cell lung cancer epidermal growth factor receptor mutation patient with brain metastasis: A case report
T Wang, R Wang, Z Dong, N Liang, P Chang - Open Medicine, 2016 - degruyter.com
Brain metastasis (BM) has been universally recognized as a poor prognostic factor in non-
small cell lung cancer (NSCLC). Epidermal growth factor receptor (EGFR) tyrosine kinase …
small cell lung cancer (NSCLC). Epidermal growth factor receptor (EGFR) tyrosine kinase …
[引用][C] Treatment with high-dose, weekly erlotinib in EGFR-mutated NSCLC-patients with extra-cranial progressive disease on standard-dose EGFR-TKIs
JL Kuiper, DAM Heideman, E Thunnissen, AW van Wijk…